JBF Capital »

Centessa Pharmaceuticals shares owned by JBF Capital

Quarter-by-quarter ownership of Centessa Pharmaceuticals (CNTA) shares owned by JBF Capital from 13F filings

Historical chart of JBF Capital investment in Centessa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Centessa Pharmaceuticals held by JBF Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Centessa Pharmaceuticals by JBF Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $830k 21k 39.72

More positions owned by JBF Capital

Vanguard S&p 500 Etf Etf (VOO)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Green Brick Partners (GRBK)
Goldman Sachs (GS)
State Street Spdr S&p Biotech Etf Etf Etf (XBI)
Facebook Inc cl a (META)
Netflix (NFLX)
Invesco S&p 500 Equal Weight Etf Etf (RSP)
Lowe's Companies (LOW)
Commercial Bancgroup (CBK)
NVIDIA Corporation (NVDA)
Korea (KF)
GSK (GSK)

View all positions for JBF Capital

Top funds holding Centessa Pharmaceuticals

Medicxi Ventures Management
venBio Select Advisor
Adage Capital Partners GP
FMR
Pentwater Capital Management
EcoR1 Capital
General Atlantic
Farallon Capital Management
Perceptive Advisors
Capital World Investors
TCG Crossover Management
Morgan Stanley
Siren
Paradigm Biocapital Advisors
Henderson Group

View all funds holding Centessa Pharmaceuticals